All In Biotech

Drug Trial Radar · NCT02367313

A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Last checked: Nov 19, 2026Latest source record: Jun 1, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 455 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

455

Actual

Start

Feb 2015

Primary completion

Dec 2016

Study completion Dec 2016

Sponsor

Lead sponsor
Biota Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Feb 20, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 2 protocol is designed to compare two dose levels of Vapendavir versus placebo. The objectives are to obtain safety and efficacy data in moderate to severe asthmatic patients, aged 18 to 75 years at risk of loss of asthma control due to presumptive Human Rhinovirus infection.

Conditions

  • Asthma

Interventions

  • VapendavirDrug

    Vapendavir 264 mg twice daily

  • VapendavirDrug

    Vapendavir 528 mg twice daily

  • PlaceboDrug

    Placebo twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Asthma Control Questionnaire-6 (ACQ-6)Time frame: Baseline (Day 1) to Study Day 14

Locations

62 sites in 6 countries. Site status is shown where the registry gives one.

  • Biota Investigational site

    Birmingham, Alabama

  • Biota Investigational site

    Flagstaff, Arizona

  • Biota Investigational site

    Bakersfield, California

  • Biota Investigational site

    Los Angeles, California

  • Biota Investigational site

    Orange, California

  • Biota Investigational Site

    San Jose, California

  • Biota Investigational site

    Stockton, California

  • Biota Investigational site

    Centennial, Colorado

  • Biota Investigational site

    Denver, Colorado

  • Biota Investigational site

    Hialeah, Florida

  • Biota Investigational site

    New Port Richey, Florida

  • Biota Investigational site

    Oviedo, Florida

  • Biota Investigation site

    Palmetto Bay, Florida

  • Biota Investigational site

    Tallahassee, Florida

  • Biota Investigational site

    Twin Falls, Idaho

  • Biota Investigational site

    Baltimore, Maryland

  • Biota Investigational site

    St Louis, Missouri

  • Biota Investigational site

    Bellevue, Nebraska

  • Biota investigational site

    Las Vegas, Nevada

  • Biota Investigational site

    Ocean City, New Jersey

  • Biota Investigational site

    Albuquerque, New Mexico

  • Biota Investigational site

    Rockville Centre, New York

  • Biota Investigational site

    Raleigh, North Carolina

  • Biota Investigational site

    Fargo, North Dakota

  • Biota Investigational site

    Middleburg, Ohio

  • Biota Investigational site

    Toledo, Ohio

  • Biota Investigation site

    Oklahoma City, Oklahoma

  • Biota Investigational site

    Medford, Oregon

  • Biota Investigational site

    Portland, Oregon

  • Biota Investigational site

    Warwick, Rhode Island

  • Biota Investigational site

    Houston, Texas

  • Biota Investigational site

    Seattle, Washington

  • Biota Investigational site

    Greenfield, Wisconsin

  • Biota Investigational site

    Rousse, Bulgaria

  • Biota Investigational site

    Sofia, Bulgaria

  • Biota Investigational site

    Sofia, Bulgaria

  • Biota Investigational site

    Sofia, Bulgaria

  • Biota Investigational site

    Sofia, Bulgaria

  • Biota Investigational site

    Stara Zagora, Bulgaria

  • Biota Investigational site

    Jindřichův Hradec, Czechia

Showing 40 of 62 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.